Skip to content

Effect of Rotation on Pronase Premedication during Endoscopy: a Randomized, Controlled Trial

Effect of Rotation on Pronase Premedication during Endoscopy: a Randomized, Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039524
Enrollment
Unknown
Registered
2020-10-30
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premedication during Endoscopy

Interventions

group A:20000u pronase, 5ml simethicone and 100ml water
group B:20000u pronase, 5ml simethicone and 100ml water+rotation
group C:20000u pronase and 100ml water+ rotation

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years, male and female; 2. tested voluntarily, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Complete pyloric obstruction; 2. Active gastrointestinal bleeding; 3. History of upper gastrointestinal surgery; 4. Severe heart, liver, and kidney dysfunction and could not accept painless endoscopy; 5. Pregnant and lactating women; 6. Participated in other clinical studies within a month; 7. Psychosis and severe neurosis; 8. Allergy to all the drugs used in the test.

Design outcomes

Primary

MeasureTime frame
visibility scores;diminutive lesions;

Secondary

MeasureTime frame
number of mucosal areas that needed cleansing;water consumption for cleansing;time taken for examination;

Countries

China

Contacts

Public ContactShi Yongjun

Shandong Provincial Hospital

shiyj2020@126.com+86 531-68773293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026